Papers 41–44 of
44
by Melvin E Andersen
- V Soldatow, RC Peffer, OJ Trask, DE Cowie, ME Andersen, E LeCluyse, and C Deisenroth. Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation. Toxicol In Vitro 36 : 224-237 (Oct 12, 2016). [abstract] [pubmed]
- JM Pedersen, YS Shim, V Hans, MB Phillips, JM Macdonald, G Walker, ME Andersen, HJ Clewell, and M Yoon. Fluid Dynamic Modeling to Support the Development of Flow-Based Hepatocyte Culture Systems for Metabolism Studies. Front Bioeng Biotechnol 4 : 72 (Sep 30, 2016). [abstract] [pubmed]
- RA Clewell, and ME Andersen. Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro. Mutagenesis 31 (3) : 333-40 (May 4, 2016). [abstract] [pubmed]
- RA Clewell, PD McMullen, Y Adeleye, PL Carmichael, and ME Andersen. Pathway Based Toxicology and Fit-for-Purpose Assays. Adv Exp Med Biol 856 : 205-230 (Jan 1, 2016). [abstract] [pubmed]